Advertisement

The Yeast Two-Hybrid Assay to Identify Interacting Proteins

  • Kenneth M. Izumi
Part of the Methods in Molecular Biology™ book series (MIMB, volume 174)

Abstract

The yeast two-hybrid assay invented by Stanley Fields and Stephen Elledge (1, 2, 3, 4) is a powerful tool to investigate protein-protein interactions, the essence of many biological processes. Owing to the adaptability of the assay procedure, the ease of manipulating and cultivating Saccharomyces cerevesiae, and the speed with which interacting proteins and their genes can be identified and characterized, this assay has been widely utilized and directly responsible for major discoveries in signal transduction and gene regulation (5, 6, 7).

Keywords

Orbital Shaker Microcentrifuge Tube Yeast Coloni Library Screen Yeast Expression Vector 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Fields, S. and Song, O. (1989) A novel genetic system to detect protein-protein interactions. Nature 340, 245–246.PubMedCrossRefGoogle Scholar
  2. 2.
    Chien, C. T., Bartel, P. L., Sternglanz, R., and Fields, S. (1991) The two-hybrid system: a method to identify and clone genes for proteins that interact with a protein of interest. Proc. Natl. Acad. Sci. USA 88, 9578–9582.PubMedCrossRefGoogle Scholar
  3. 3.
    Bai, C. and Elledge, S. J. (1997) Gene identification using the yeast two-hybrid system. Methods Enzymol. 283, 141–156.PubMedCrossRefGoogle Scholar
  4. 4.
    Bartel, P. L. and Fields, S.(1995) Analyzing protein-protein interactions using two-hybrid system. Methods Enzymol. 254, 241–263.PubMedCrossRefGoogle Scholar
  5. 5.
    Rothe, M., Wong, S. C., Henzel, W. J., and Goeddel, D. V. (1994) A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78, 681–692.PubMedCrossRefGoogle Scholar
  6. 6.
    Hsu, H., Xiong, J., and Goeddel, D. V. (1995) The TNF receptor 1–associated protein TRADD signals cell death and NF-kappa B activation. Cell 81, 495–504.PubMedCrossRefGoogle Scholar
  7. 7.
    Regnier, C. H., Song, H. Y., Gao, X., Goeddel, D. V., Cao, Z., and Rothe M. (1997) Identification and characterization of an IkappaB kinase. Cell 90, 373–383.PubMedCrossRefGoogle Scholar
  8. 8.
    Mosialos, G., Birkenbach, M., Yalamanchili, R., VanArsdale, T., Ware, C., and Kieff, E. (1995) The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80, 389–399.PubMedCrossRefGoogle Scholar
  9. 9.
    Izumi, K. M. and Kieff. E. D. (1997) The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB. Proc. Natl. Acad. Sci. USA 94, 12,592–12,597.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc., Totowa, NJ 2001

Authors and Affiliations

  • Kenneth M. Izumi
    • 1
  1. 1.Brigham and Women’s HospitalBoston

Personalised recommendations